Neuronetics Inc. (NASDAQ:STIM) is one of the best-performing NASDAQ stocks according to analysts. On June 10, Neuronetics announced its significant presence at the 13th Annual Clinical TMS ...

MALVERN, Pa., Sept. 08, 2026 (GLOBE NEWSWIRE)-- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health and provider of NeuroStar® TMS technology and direct patient care through the ...

Northeast Health Services now offers NeuroStar TMS therapy in Boston, providing an innovative, non-drug treatment for depression. BOSTON, MA, UNITED STATES, May 26 ...

MALVERN, Pa., Nov. 21, 2016 /PRNewswire/ -- NeuroStar announced today the launch of the largest depression outcomes registry ever in patients treated with its TMS (transcranial magnetic stimulation) ...

NEW YORK, May 6, 2014 – Neuronetics, Inc. announced today a new analysis of data at the annual meeting of the American Psychiatric Association that shows Transcranial Magnetic Stimulation (TMS) ...

MALVERN, Pa., March 24, 2016 /PRNewswire/ -- Neuronetics, Inc. announced today the publication of a recent study in Brain Stimulation - "Can Medication Free, Treatment-Resistant, Depressed Patients ...

MALVERN, Pa., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life ...

MALVERN, Pa., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the ...

Last year, Neuronetics’ NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy system became the first device of its kind to be cleared by the FDA for treating depression. Although, the similarity ...

MALVERN, Pa., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. STIM, a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality ...